Clinical implications of new neuromuscular concepts and agents. So long, neostigmine! So long, sux!

Journal of Critical Care

Volumn 24, Issue 1, 2009, Pages 43-49

  Lee, Chingmuh ^a   Katz, Ronald L ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Neostigmine; Neuromuscular block; Neuromuscular reversal; Succinylcholine; Sugammadex

Indexed keywords

3,4 DIAMINOPYRIDINE; 4 AMINOPYRIDINE; ATROPINE; AV 002; CHOLINERGIC RECEPTOR STIMULATING AGENT; DANTROLENE; DOXACURIUM; EDROPHONIUM; GERMINE 3 ACETATE; GW 280430A; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; PIPECURONIUM; RAPACURONIUM BROMIDE; ROCURONIUM; SUGAMMADEX; SUXAMETHONIUM; TAAC3; UNCLASSIFIED DRUG; VECURONIUM;

ANESTHESIA; BRADYCARDIA; CHOLINESTERASE BLOOD LEVEL; DRUG SAFETY; ENDOTRACHEAL INTUBATION; FASCICULATION; HEART ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPERMETABOLISM; HYPERTHERMIA; MEDICAL PRACTICE; MUSCLE SPASM; MYALGIA; NERVE EXCITABILITY; NEUROMUSCULAR BLOCKING; RESPIRATORY FAILURE; REVIEW; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; CHEMISTRY, PHARMACEUTICAL; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; DRUG MONITORING; DRUG UTILIZATION; EDROPHONIUM; FORECASTING; GAMMA-CYCLODEXTRINS; HUMANS; MONITORING, INTRAOPERATIVE; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PATIENT SELECTION; PYRIDOSTIGMINE BROMIDE; SAFETY; SUCCINYLCHOLINE; VECURONIUM BROMIDE;

EID: 61449233985     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2008.08.009     Document Type: Review

References (14)

1. Bowman W.C., Rand M.J. Peripheral autonomic cholinergic mechanisms; 1980. Chapter 10, textbook of pharmacology, 2nd ed., Oxford Black Well Scientific Publications, London, Edinburgh, Boston, Melbourne, Paris, Berlin, Vienna.
2. Lee C. Succinylcholine: its past, present, and future. In: Katz R.L. (Ed). Muscle relaxants, basic and clinical aspects (1984), Grune & Stratton, Orlando 69-85
3. Foldes F.F., McNall P.G., and Borrego-Hinojosa J.M. Succinylcholine: a new approach to muscular relaxation in anesthesiology. N Engl J Med 247 (1952) 596-600
4. Lee C, Jahr JS, Candiotti KA, et al: Reversal of profound neuromuscular block by sugammadex administered 3 minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. (personal information, manuscript in preparation, data on file)
5. Durant N.N., Nguyen N., Lee C., et al. A comparison of 3,4-diaminopyridine and 4-aminopyridine in the anaesthetized cat. Eur J Pharmacol 84-3 (1982) 215-219
6. Benumof J.L., Dagg R., and Benumof R. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology 87 (1997) 979-982
7. Savarese J.J., Ginsburg S., Lee C., et al. The pharmacology of new short-acting nondepolarizing ester neuromuscular blocking agents: clinical implications. Anesth Analg 52-6 (1973) 982-988
8. Gyermek L., Lee C., Cho Y.M., et al. Neuromuscular pharmacology of TAAC3, a new nondepolarizing muscle relaxant with rapid onset and ultrashort duration of action. Anesth Analg 94-4 (2002) 879-885
9. Boros E.E., Bigham E.C., Boswell G.E., et al. Bis- and mixed-tetrahydroisoquinolinium chlorofumarates: new ultra-short-acting nondepolarizing neuromuscular blockers. J Med Chem 42 (1999) 206-209
10. Belmont M.R., Lien C.A., Tjan J., et al. Clinical pharmacology of GW280430A in humans. Anesthesiology 100-4 (2004) 768-773
11. Katz R.L. A nerve stimulator for the continuous monitoring of muscle relaxant action. Anesthesiology 26-6 (1969) 832-833
12. Lee C.M. Train-of-4 quantitation of competitive neuromuscular block. Anesth Analg 54-5 (1975) 649-653
13. Katz R.L. Clinical neuromuscular pharmacology of pancuronium. Anesthesiology 34-6 (1971) 550-556
14. Kopman A.F., Klewicka M.M., Kopman D.J., et al. Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration. Anesthesiology 90 (1999) 425-431